A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma.

By P. Rougier, A. Adenis, Michel Ducreux, M. Forni, J. Bonneterre, M. Dembak, P. Clouet, A. Lebecq, P. Baille, F. Lefresne-Soulas and 2 more. European Journal of Cancer, 2000

769 citations recorded by the source corpus.

Subfields: Oncology

View Paper: https://www.semanticscholar.org/paper/41da36f974960bc7688d12872fe6b54996d3f9c2